In a report released today, Heiko Ihle from H.C. Wainwright reiterated a Buy rating on Penumbra Inc (PEN), with a price target of $0.90. The company’s shares closed yesterday at $134.39.
According to TipRanks.com, Ihle ‘s ranking currently consits of no stars on a 0-5 ranking scale, with an average return of -6.2% and a 37.9% success rate. Ihle covers the Basic Materials sector, focusing on stocks such as Solitario Exploration & Royalty, Americas Silver Corporation, and Golden Star Resources Ltd.
Penumbra Inc has an analyst consensus of Moderate Buy, with a price target consensus of $160.
See today’s analyst top recommended stocks >>
The company has a one-year high of $167.35 and a one-year low of $110.84. Currently, Penumbra Inc has an average volume of 372.9K.
Based on the recent corporate insider activity of 46 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of PEN in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Penumbra, Inc. engages in the design, development, manufacture, and marketing of innovative medical devices. It offers thrombectomy, embolization, access, neurosurgical tools, ruby coil system, lantern, penumbra occlusion device (POD) system, packing coil, and indigo systems products.